Skip to main content

Table 4 Suspected diagnosis in the sample

From: The Sierra Leone Ultrasound Rainbow4Africa Project (SLURP): an observational study of ultrasound effectiveness in developing countries

Suspected diagnosis

Before-US

N (%)

After-US

N (%)

Ruled out

N (%a)

Added

N (%b)

Pneumonia/TB

9

(4.6)

3

(1.9)

8

(88.9)

2

(66.7)

Pleural effusion

5

(2.6)

4

(2.5)

3

(60.0)

2

(50.0)

Pulmonary overload

0

(0.0)

3

(1.9)

0

3

(100)

Cardiomyopathy

12

(6.2)

6

(3.8)

7

(58.3)

1

(16.7)

Aortic ectasia

0

(0.0)

2

(1.3)

0

2

(100)

Liver cirrhosis/schistosomiasis

12

(6.2)

12

(7.6)

8

(66.7)

8

(66.7)

Cholecystolithiasis

0

(0.0)

1

(0.6)

0

1

(100)

PUD

27

(13.9)

24

(15.2)

6

(22.2)

3

(12.5)

Gastritis/gerd

10

(5.2)

7

(4.4)

5

(50.0)

2

(28.6)

Gastroenteritis

6

(3.1)

5

(3.2)

2

(33.3)

1

(20.0)

Appendicitis

2

(1.0)

0

(0.0)

2

(100.0)

0

Acute/chronic nephritis

7

(3.6)

5

(3.2)

3

(42.9)

1

(20.0)

Nephrolithiasis/hydronephrosis

2

(1.0)

1

(0.6)

2

(100)

1

(100)

Abscess/mass

11

(5.7)

16

(10.1)

4

(36.4)

9

(56.3)

BPM

0

(0.0)

1

(0.6)

0

1

(100)

Pelvic muscle syndrome

5

(2.6)

3

(1.9)

2

(40.0)

0

(0.0)

Splenomegaly

5

(2.6)

4

(2.5)

4

(80.0)

3

(75.0)

Musculoskeletal pain

2

(1.0)

4

(2.5)

1

(50.0)

3

(75.0)

Gynaecomastia

0

(0.0)

1

(0.6)

0

1

(100)

Adnexitis/gut infection

34

(17.5)

25

(15.8)

11

(32.4)

2

(8.0)

Ovarian cyst

16

(8.2)

8

(5.1)

11

(68.8)

3

(37.5)

Uterus myomatosis

7

(3.6)

2

(1.3)

6

(85.7)

1

(50.0)

Miscarriage

5

(2.6)

3

(1.9)

2

(40.0)

0

(0.0)

Pregnancy

17

(8.8)

18

(11.4)

2

(11.8)

3

(16.7)

Total (%)

194

(100)

158

(100)

89

(45.9)

53

33.5

  1. First column: before ultrasound, based on clinical presentation. Second column: after the requested ultrasound scan and considering both the clinical and sonographical data. Third column: number of initial hypothesis excluded due to the ultrasound findings. Fourth column: number of final hypothesis added due to the ultrasound findings
  2. aPercentage of ddx pre-US that has been excluded on US basis
  3. bPercentage of ddx post-US that has been added on US basis